vs
Gossamer Bio, Inc.（GOSS）与Pioneer Bancorp, Inc.（PBFS）财务数据对比。点击上方公司名可切换其他公司
Pioneer Bancorp, Inc.的季度营收约是Gossamer Bio, Inc.的1.8倍（$25.0M vs $13.8M），Pioneer Bancorp, Inc.净利率更高（82.1% vs -342.3%，领先424.4%）
Gossamer Bio是一家临床阶段生物制药企业，专注于发现、开发和商业化用于治疗免疫、炎症和肿瘤领域重症疾病的创新疗法，推进多条自研候选药物管线进入不同临床阶段，主要面向北美及全球其他地区的医疗市场。
先锋银行控股公司（马里兰州）是一家美国银行控股企业，为先锋银行的母公司，主要面向马里兰州本地社区用户提供零售及商业银行服务，涵盖存款账户、住房与商业抵押贷款、消费贷款及小微企业融资等产品。
GOSS vs PBFS — 直观对比
营收规模更大
PBFS
是对方的1.8倍
$13.8M
净利率更高
PBFS
高出424.4%
-342.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.8M | $25.0M |
| 净利润 | $-47.2M | $3.7M |
| 毛利率 | — | — |
| 营业利润率 | -333.6% | 21.3% |
| 净利率 | -342.3% | 82.1% |
| 营收同比 | 47.1% | — |
| 净利润同比 | -43.0% | — |
| 每股收益（稀释后） | $-0.21 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GOSSPBFS
| Q4 25 | $13.8M | $25.0M | ||
| Q3 25 | $13.3M | $24.0M | ||
| Q2 25 | — | $24.4M | ||
| Q1 25 | — | $22.8M | ||
| Q3 24 | — | $22.0M | ||
| Q2 24 | $95.8M | $20.9M | ||
| Q1 24 | $0 | $21.6M | ||
| Q4 23 | — | $4.2M |
净利润GOSSPBFS
| Q4 25 | $-47.2M | $3.7M | ||
| Q3 25 | $-48.2M | $4.3M | ||
| Q2 25 | — | $6.5M | ||
| Q1 25 | — | $5.8M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | $49.2M | $3.9M | ||
| Q1 24 | $-41.9M | $4.7M | ||
| Q4 23 | — | $3.2M |
营业利润率GOSSPBFS
| Q4 25 | -333.6% | 21.3% | ||
| Q3 25 | -369.4% | 23.4% | ||
| Q2 25 | — | 33.3% | ||
| Q1 25 | — | 32.5% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | 54.3% | 24.1% | ||
| Q1 24 | — | 28.1% | ||
| Q4 23 | — | 96.1% |
净利率GOSSPBFS
| Q4 25 | -342.3% | 82.1% | ||
| Q3 25 | -362.7% | 18.0% | ||
| Q2 25 | — | 26.4% | ||
| Q1 25 | — | 25.3% | ||
| Q3 24 | — | 28.7% | ||
| Q2 24 | 51.4% | 107.4% | ||
| Q1 24 | — | 21.9% | ||
| Q4 23 | — | 76.4% |
每股收益（稀释后）GOSSPBFS
| Q4 25 | $-0.21 | $0.16 | ||
| Q3 25 | $-0.21 | $0.18 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.23 | ||
| Q3 24 | — | $0.25 | ||
| Q2 24 | $0.22 | $0.15 | ||
| Q1 24 | $-0.19 | $0.19 | ||
| Q4 23 | — | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $136.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-122.8M | $323.9M |
| 总资产 | $172.2M | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GOSSPBFS
| Q4 25 | $136.9M | — | ||
| Q3 25 | $180.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $354.5M | — | ||
| Q1 24 | $244.4M | — | ||
| Q4 23 | — | — |
股东权益GOSSPBFS
| Q4 25 | $-122.8M | $323.9M | ||
| Q3 25 | $-82.3M | $314.2M | ||
| Q2 25 | — | $314.2M | ||
| Q1 25 | — | $310.7M | ||
| Q3 24 | — | $303.8M | ||
| Q2 24 | $81.5M | $296.5M | ||
| Q1 24 | $26.7M | $289.0M | ||
| Q4 23 | — | $283.8M |
总资产GOSSPBFS
| Q4 25 | $172.2M | $2.2B | ||
| Q3 25 | $208.8M | $2.2B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.1B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $373.4M | — | ||
| Q1 24 | $259.4M | $2.0B | ||
| Q4 23 | — | $1.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-48.3M | $11.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 2.97× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GOSSPBFS
| Q4 25 | $-48.3M | $11.1M | ||
| Q3 25 | $-36.2M | $3.9M | ||
| Q2 25 | — | $5.1M | ||
| Q1 25 | — | $-3.5M | ||
| Q3 24 | — | $1.9M | ||
| Q2 24 | $116.3M | $9.0M | ||
| Q1 24 | $-52.3M | $3.3M | ||
| Q4 23 | — | $-943.0K |
资本支出强度GOSSPBFS
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
现金转化率GOSSPBFS
| Q4 25 | — | 2.97× | ||
| Q3 25 | — | 0.90× | ||
| Q2 25 | — | 0.78× | ||
| Q1 25 | — | -0.61× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | 2.36× | 2.30× | ||
| Q1 24 | — | 0.70× | ||
| Q4 23 | — | -0.30× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
